Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kohjin Bio CoTSE:177A +1.57%19 EBIT per Share is 円72.44 as of Mar. 2026. GuruFocus rates TSE:177A with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 1,171 Biotechnology companies, Kohjin Bio Co ranks worse than 93.6% on this metric.
Kohjin Bio Co's EBIT per Share for the
six
months ended in Mar. 2026 was 円15.14.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円72.44.
During the past 12 months, the average EBIT per Share Growth Rate of Kohjin Bio Co was -66.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -39.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Kohjin Bio Co's EBIT per Share or its related term are showing as below:
TSE:177A'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -39.7 Med: -19.6 Max: 0.5
Current: -39.7
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Kohjin Bio Co was 0.50% per year. The lowest was -39.70% per year. And the median was -19.60% per year.
TSE:177A's 3-Year EBIT Growth Rate is ranked worse than 93.6% of 1171
companies
in the Biotechnology industry
Industry Median: 15.5
vs TSE:177A: -39.70
Kohjin Bio Co's EBIT for the
six
months ended in Mar. 2026 was 円77 Mil.
Kohjin Bio Co (TSE:177A) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Kohjin Bio Co EBIT per Share Related Terms
Kohjin Bio Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Kohjin Bio Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円72.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kohjin Bio Co (TSE:177A) has a EBIT per Share of 円72.44 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kohjin Bio Co and its competitors. According to the industry distribution chart, Kohjin Bio Co ranks #1096 out of 1171 companies in the Biotechnology industry, placing it in the top 93.6%.
Is Kohjin Bio Co's EBIT per Share too high?
Kohjin Bio Co's current EBIT per Share is 円72.44. Based on the distribution chart, Kohjin Bio Co ranks #1096 out of 1171 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #1096 out of 1171 companies for EBIT per Share. This places Kohjin Bio Co in the lower half of its industry. The industry median EBIT per Share is 15.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.50, based on 1,171 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kohjin Bio Co and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kohjin Bio Co's current EBIT per Share is 円72.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current EBIT per Share of 円72.44. The current EBIT per Share is 円72.44. Kohjin Bio Co's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current EBIT per Share is 円72.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
19GF Score
Get the complete analysis for TSE:177A
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 
